Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced the launch of its MiToe™ patient outreach program to increase awareness of treatment options for hammertoes. MiToe™ is now the patient-facing brand for Wright’s hammertoe solutions, which include the PRO-TOE™ VO Hammertoe Fixation System. Beginning at this week’s American Orthopaedic Foot & Ankle Society (AOFAS) meeting, foot and ankle doctors will be introduced to this new initiative from Wright Medical.
Wright Medical Group, Inc. Announces the Launch of MiToe(TM) Hammertoe Patient Outreach Program (Photo: Business Wire)
As part of this initiative, Wright’s MiToe™ hammertoe program website is now live and can be accessed at
“We are pleased to announce the launch of the MiToe™ patient outreach program, including the MiToe.com website,” stated Robert Palmisano, President and Chief Executive Officer of Wright Medical. “This patient education site, along with our planned new product launches, is part of our company’s focus on growing our foot and ankle business faster than the market rate by targeting the largest sufferers of painful hammertoes--women in their 40s to 60s. Our objective with this website launch is to educate patients and encourage them to visit a foot and ankle specialist and ask about treatment options including the MiToe™ implant.”
Hammertoes are one of the most common deformities of the lesser toes. In the U.S. alone, an estimated 500,000 surgical procedures (representing approximately 1 million toes) are performed each year to treat hammertoes.¹ Today, the majority of these hammertoes are treated with wire pins (also known as “K-wires”), but many patients complain about the inconveniences that come with the wires being exposed out the end of the toe for several weeks - from limitations in activities and shoewear to breakage and dislodgement of the wires.² Advances in implant design have made hammertoe implants, including the PRO-TOE™ VO Hammertoe Fixation System, a feasible surgical option for many people. Once inserted, the implant remains within the bone, permanently correcting the pain and deformity of hammertoes, thereby eliminating many of the complications specific to wires.